SPONSOR
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Total Trials
2
Recruiting
2
Phases
Phase 2
Shenzhen Salubris Pharmaceuticals Co., Ltd. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Uncontrolled Hypertension, Anemia.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shenzhen Salubris Pharmaceuticals Co., Ltd.
How many clinical trials has Shenzhen Salubris Pharmaceuticals Co., Ltd. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Shenzhen Salubris Pharmaceuticals Co., Ltd., of which 2 are actively recruiting participants. These trials cover conditions including Uncontrolled Hypertension, Anemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shenzhen Salubris Pharmaceuticals Co., Ltd. research focus on?
Shenzhen Salubris Pharmaceuticals Co., Ltd. clinical trials span Uncontrolled Hypertension, Anemia. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shenzhen Salubris Pharmaceuticals Co., Ltd. clinical trial?
To participate in a Shenzhen Salubris Pharmaceuticals Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shenzhen Salubris Pharmaceuticals Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Shenzhen Salubris Pharmaceuticals Co., Ltd.
NCT07654140 Phase 2
Recruiting
A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Uncontrolled Hypertension
Uncontrolled Hypertension
NCT06737081 Phase 2
Recruiting
SAL-0951 in the Treatment of Chemotherapy-induced Anemia in Patients With Non-myeloid Malignancies
Anemia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology